Evogene Ltd

詳細情報 Evogene Ltd 企業名

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

企業情報

企業コードEVGN

会社名Evogene Ltd

上場日Jun 11, 2007

最高経営責任者「CEO」Dr. Arnon Heyman

従業員数117

証券種類Ordinary Share

決算期末Jun 11

本社所在地13 Gad Feinstein Street

都市REHOVOT

証券取引所NASDAQ Capital Market Consolidated

国Israel

郵便番号7638517

電話番号97289311900

ウェブサイトhttps://evogene.com/

企業コードEVGN

上場日Jun 11, 2007

最高経営責任者「CEO」Dr. Arnon Heyman

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Leon Yehuda Recanati

Independent Director

83.89K

--

Dr. Arnon Heyman

Chief Executive Officer of Canonic Limited

--

Mr. Ofer Haviv

President, Chief Executive Officer

--

Dr. Adrian Percy

Independent Director

--

Ms. Sarit Firon

Independent Director

--

Dr. Oded Shoseyov, Ph.D.

Independent Director

--

Kenny Green

Investor Relations

--

Ms. Dorit Kreiner

Chief Financial Officer

--

Mr. Dan Michael Falk

Independent Director

--

Dr. Brian Ember

Chief Executive Officer of AgPlenus Limited

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Leon Yehuda Recanati

Independent Director

83.89K

--

Dr. Arnon Heyman

Chief Executive Officer of Canonic Limited

--

Mr. Ofer Haviv

President, Chief Executive Officer

--

Dr. Adrian Percy

Independent Director

--

Ms. Sarit Firon

Independent Director

--

Dr. Oded Shoseyov, Ph.D.

Independent Director

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2024

FY2018

データなし

地域別USD

会社名

収益

比率

Other

4.00M

47.00%

United States

3.92M

46.00%

Israel

595.77K

7.00%

事業別

地域別

データなし

株主

更新時刻: Sat, Aug 2

株主統計

種類

株主統計

比率

Armistice Capital LLC

3.63%

Recanati (Leon Yehuda)

0.96%

Jane Street Capital, L.L.C.

0.39%

UBS Financial Services, Inc.

0.22%

Morgan Stanley & Co. LLC

0.17%

Other

94.64%

株主統計

比率

Armistice Capital LLC

3.63%

Recanati (Leon Yehuda)

0.96%

Jane Street Capital, L.L.C.

0.39%

UBS Financial Services, Inc.

0.22%

Morgan Stanley & Co. LLC

0.17%

Other

94.64%

種類

株主統計

比率

Hedge Fund

3.78%

Individual Investor

0.96%

Research Firm

0.71%

Investment Advisor

0.34%

Venture Capital

0.12%

Investment Advisor/Hedge Fund

0.05%

Other

94.04%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

53

519.37K

5.96%

-412.34K

2025Q1

55

520.29K

6.01%

-409.22K

2024Q4

56

495.82K

9.24%

-272.31K

2024Q3

56

646.41K

12.68%

+45.84K

2024Q2

57

498.30K

80.86%

-140.56K

2024Q1

62

510.64K

10.05%

-122.17K

2023Q4

69

544.86K

11.19%

-474.65K

2023Q3

76

590.60K

14.30%

-53.35K

2023Q2

75

185.66K

4.46%

-461.57K

2023Q1

80

194.62K

4.68%

-499.69K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Armistice Capital LLC

316.02K

3.63%

+17.74K

+5.95%

Mar 31, 2025

Recanati (Leon Yehuda)

83.89K

0.96%

--

Mar 17, 2025

Jane Street Capital, L.L.C.

33.73K

0.39%

+12.39K

+58.03%

Mar 31, 2025

UBS Financial Services, Inc.

18.75K

0.22%

-3.27K

-14.84%

Mar 31, 2025

Morgan Stanley & Co. LLC

14.56K

0.17%

--

Mar 31, 2025

Two Sigma Investments, LP

13.56K

0.16%

+2.40K

+21.53%

Mar 31, 2025

BNP Paribas Securities Corp. North America

12.82K

0.15%

--

Mar 31, 2025

XTX Markets LLC

10.18K

0.12%

+10.18K

--

Mar 31, 2025

P&S Vermögensberatungs AG Performance & Sicherheit

10.00K

0.11%

--

Mar 31, 2025

Geode Capital Management, L.L.C.

4.20K

0.05%

--

May 31, 2025

詳細を見る

1.185USD

Evogene Ltd

1.185

概要

企業名

金融